Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Molecular Influenza Diagnostic Revenue 1.4 Market Analysis by Type 1.4.1 Global Molecular Influenza Diagnostic Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Reverse Transcription Polymerase Chain Reaction (RT-PCR) 1.4.3 Nucleic Acid Sequence Based Amplification (NASBA) Tests 1.4.4 Loop-mediated Isothermal Amplification-Based Assays (LAMP) 1.4.5 Simple Amplification-based Assays (SAMBA) 1.5 Market by Application 1.5.1 Global Molecular Influenza Diagnostic Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 POCT 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Molecular Influenza Diagnostic Market Perspective (2015-2026) 2.2 Molecular Influenza Diagnostic Growth Trends by Regions 2.2.1 Molecular Influenza Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Molecular Influenza Diagnostic Historic Market Share by Regions (2015-2020) 2.2.3 Molecular Influenza Diagnostic Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Molecular Influenza Diagnostic Market Growth Strategy 2.3.6 Primary Interviews with Key Molecular Influenza Diagnostic Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Molecular Influenza Diagnostic Players by Market Size 3.1.1 Global Top Molecular Influenza Diagnostic Players by Revenue (2015-2020) 3.1.2 Global Molecular Influenza Diagnostic Revenue Market Share by Players (2015-2020) 3.1.3 Global Molecular Influenza Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Molecular Influenza Diagnostic Market Concentration Ratio 3.2.1 Global Molecular Influenza Diagnostic Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Molecular Influenza Diagnostic Revenue in 2019 3.3 Molecular Influenza Diagnostic Key Players Head office and Area Served 3.4 Key Players Molecular Influenza Diagnostic Product Solution and Service 3.5 Date of Enter into Molecular Influenza Diagnostic Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Molecular Influenza Diagnostic Historic Market Size by Type (2015-2020) 4.2 Global Molecular Influenza Diagnostic Forecasted Market Size by Type (2021-2026) 5 Molecular Influenza Diagnostic Breakdown Data by Application (2015-2026) 5.1 Global Molecular Influenza Diagnostic Market Size by Application (2015-2020) 5.2 Global Molecular Influenza Diagnostic Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Molecular Influenza Diagnostic Market Size (2015-2020) 6.2 Molecular Influenza Diagnostic Key Players in North America (2019-2020) 6.3 North America Molecular Influenza Diagnostic Market Size by Type (2015-2020) 6.4 North America Molecular Influenza Diagnostic Market Size by Application (2015-2020) 7 Europe 7.1 Europe Molecular Influenza Diagnostic Market Size (2015-2020) 7.2 Molecular Influenza Diagnostic Key Players in Europe (2019-2020) 7.3 Europe Molecular Influenza Diagnostic Market Size by Type (2015-2020) 7.4 Europe Molecular Influenza Diagnostic Market Size by Application (2015-2020) 8 China 8.1 China Molecular Influenza Diagnostic Market Size (2015-2020) 8.2 Molecular Influenza Diagnostic Key Players in China (2019-2020) 8.3 China Molecular Influenza Diagnostic Market Size by Type (2015-2020) 8.4 China Molecular Influenza Diagnostic Market Size by Application (2015-2020) 9 Japan 9.1 Japan Molecular Influenza Diagnostic Market Size (2015-2020) 9.2 Molecular Influenza Diagnostic Key Players in Japan (2019-2020) 9.3 Japan Molecular Influenza Diagnostic Market Size by Type (2015-2020) 9.4 Japan Molecular Influenza Diagnostic Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Molecular Influenza Diagnostic Market Size (2015-2020) 10.2 Molecular Influenza Diagnostic Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Molecular Influenza Diagnostic Market Size by Type (2015-2020) 10.4 Southeast Asia Molecular Influenza Diagnostic Market Size by Application (2015-2020) 11 India 11.1 India Molecular Influenza Diagnostic Market Size (2015-2020) 11.2 Molecular Influenza Diagnostic Key Players in India (2019-2020) 11.3 India Molecular Influenza Diagnostic Market Size by Type (2015-2020) 11.4 India Molecular Influenza Diagnostic Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Molecular Influenza Diagnostic Market Size (2015-2020) 12.2 Molecular Influenza Diagnostic Key Players in Central & South America (2019-2020) 12.3 Central & South America Molecular Influenza Diagnostic Market Size by Type (2015-2020) 12.4 Central & South America Molecular Influenza Diagnostic Market Size by Application (2015-2020) 13Key Players Profiles 13.1 BD 13.1.1 BD Company Details 13.1.2 BD Business Overview and Its Total Revenue 13.1.3 BD Molecular Influenza Diagnostic Introduction 13.1.4 BD Revenue in Molecular Influenza Diagnostic Business (2015-2020)) 13.1.5 BD Recent Development 13.2 Abbott (Include Alere) 13.2.1 Abbott (Include Alere) Company Details 13.2.2 Abbott (Include Alere) Business Overview and Its Total Revenue 13.2.3 Abbott (Include Alere) Molecular Influenza Diagnostic Introduction 13.2.4 Abbott (Include Alere) Revenue in Molecular Influenza Diagnostic Business (2015-2020) 13.2.5 Abbott (Include Alere) Recent Development 13.3 Roche 13.3.1 Roche Company Details 13.3.2 Roche Business Overview and Its Total Revenue 13.3.3 Roche Molecular Influenza Diagnostic Introduction 13.3.4 Roche Revenue in Molecular Influenza Diagnostic Business (2015-2020) 13.3.5 Roche Recent Development 13.4 SIEMENS 13.4.1 SIEMENS Company Details 13.4.2 SIEMENS Business Overview and Its Total Revenue 13.4.3 SIEMENS Molecular Influenza Diagnostic Introduction 13.4.4 SIEMENS Revenue in Molecular Influenza Diagnostic Business (2015-2020) 13.4.5 SIEMENS Recent Development 13.5 Analytik Jena 13.5.1 Analytik Jena Company Details 13.5.2 Analytik Jena Business Overview and Its Total Revenue 13.5.3 Analytik Jena Molecular Influenza Diagnostic Introduction 13.5.4 Analytik Jena Revenue in Molecular Influenza Diagnostic Business (2015-2020) 13.5.5 Analytik Jena Recent Development 13.6 Quidel 13.6.1 Quidel Company Details 13.6.2 Quidel Business Overview and Its Total Revenue 13.6.3 Quidel Molecular Influenza Diagnostic Introduction 13.6.4 Quidel Revenue in Molecular Influenza Diagnostic Business (2015-2020) 13.6.5 Quidel Recent Development 13.7 Thermo Fisher 13.7.1 Thermo Fisher Company Details 13.7.2 Thermo Fisher Business Overview and Its Total Revenue 13.7.3 Thermo Fisher Molecular Influenza Diagnostic Introduction 13.7.4 Thermo Fisher Revenue in Molecular Influenza Diagnostic Business (2015-2020) 13.7.5 Thermo Fisher Recent Development 13.8 Meridian Bioscience 13.8.1 Meridian Bioscience Company Details 13.8.2 Meridian Bioscience Business Overview and Its Total Revenue 13.8.3 Meridian Bioscience Molecular Influenza Diagnostic Introduction 13.8.4 Meridian Bioscience Revenue in Molecular Influenza Diagnostic Business (2015-2020) 13.8.5 Meridian Bioscience Recent Development 13.9 BioMerieux 13.9.1 BioMerieux Company Details 13.9.2 BioMerieux Business Overview and Its Total Revenue 13.9.3 BioMerieux Molecular Influenza Diagnostic Introduction 13.9.4 BioMerieux Revenue in Molecular Influenza Diagnostic Business (2015-2020) 13.9.5 BioMerieux Recent Development 13.10 Sekisui Diagnostics 13.10.1 Sekisui Diagnostics Company Details 13.10.2 Sekisui Diagnostics Business Overview and Its Total Revenue 13.10.3 Sekisui Diagnostics Molecular Influenza Diagnostic Introduction 13.10.4 Sekisui Diagnostics Revenue in Molecular Influenza Diagnostic Business (2015-2020) 13.10.5 Sekisui Diagnostics Recent Development 13.11 Response Biomedical 10.11.1 Response Biomedical Company Details 10.11.2 Response Biomedical Business Overview and Its Total Revenue 10.11.3 Response Biomedical Molecular Influenza Diagnostic Introduction 10.11.4 Response Biomedical Revenue in Molecular Influenza Diagnostic Business (2015-2020) 10.11.5 Response Biomedical Recent Development 13.12 SA Scientific 10.12.1 SA Scientific Company Details 10.12.2 SA Scientific Business Overview and Its Total Revenue 10.12.3 SA Scientific Molecular Influenza Diagnostic Introduction 10.12.4 SA Scientific Revenue in Molecular Influenza Diagnostic Business (2015-2020) 10.12.5 SA Scientific Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Molecular Influenza Diagnostic Key Market Segments Table 2. Key Players Covered: Ranking by Molecular Influenza Diagnostic Revenue Table 3. Ranking of Global Top Molecular Influenza Diagnostic Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Molecular Influenza Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Reverse Transcription Polymerase Chain Reaction (RT-PCR) Table 6. Key Players of Nucleic Acid Sequence Based Amplification (NASBA) Tests Table 7. Key Players of Loop-mediated Isothermal Amplification-Based Assays (LAMP) Table 8. Key Players of Simple Amplification-based Assays (SAMBA) Table 9. Global Molecular Influenza Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Molecular Influenza Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Molecular Influenza Diagnostic Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Molecular Influenza Diagnostic Market Share by Regions (2015-2020) Table 13. Global Molecular Influenza Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Molecular Influenza Diagnostic Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Molecular Influenza Diagnostic Market Growth Strategy Table 19. Main Points Interviewed from Key Molecular Influenza Diagnostic Players Table 20. Global Molecular Influenza Diagnostic Revenue by Players (2015-2020) (Million US$) Table 21. Global Molecular Influenza Diagnostic Market Share by Players (2015-2020) Table 22. Global Top Molecular Influenza Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Influenza Diagnostic as of 2019) Table 23. Global Molecular Influenza Diagnostic by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Molecular Influenza Diagnostic Product Solution and Service Table 26. Date of Enter into Molecular Influenza Diagnostic Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Molecular Influenza Diagnostic Market Size by Type (2015-2020) (Million US$) Table 29. Global Molecular Influenza Diagnostic Market Size Share by Type (2015-2020) Table 30. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2021-2026) Table 31. Global Molecular Influenza Diagnostic Market Size Share by Application (2015-2020) Table 32. Global Molecular Influenza Diagnostic Market Size by Application (2015-2020) (Million US$) Table 33. Global Molecular Influenza Diagnostic Market Size Share by Application (2021-2026) Table 34. North America Key Players Molecular Influenza Diagnostic Revenue (2019-2020) (Million US$) Table 35. North America Key Players Molecular Influenza Diagnostic Market Share (2019-2020) Table 36. North America Molecular Influenza Diagnostic Market Size by Type (2015-2020) (Million US$) Table 37. North America Molecular Influenza Diagnostic Market Share by Type (2015-2020) Table 38. North America Molecular Influenza Diagnostic Market Size by Application (2015-2020) (Million US$) Table 39. North America Molecular Influenza Diagnostic Market Share by Application (2015-2020) Table 40. Europe Key Players Molecular Influenza Diagnostic Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Molecular Influenza Diagnostic Market Share (2019-2020) Table 42. Europe Molecular Influenza Diagnostic Market Size by Type (2015-2020) (Million US$) Table 43. Europe Molecular Influenza Diagnostic Market Share by Type (2015-2020) Table 44. Europe Molecular Influenza Diagnostic Market Size by Application (2015-2020) (Million US$) Table 45. Europe Molecular Influenza Diagnostic Market Share by Application (2015-2020) Table 46. China Key Players Molecular Influenza Diagnostic Revenue (2019-2020) (Million US$) Table 47. China Key Players Molecular Influenza Diagnostic Market Share (2019-2020) Table 48. China Molecular Influenza Diagnostic Market Size by Type (2015-2020) (Million US$) Table 49. China Molecular Influenza Diagnostic Market Share by Type (2015-2020) Table 50. China Molecular Influenza Diagnostic Market Size by Application (2015-2020) (Million US$) Table 51. China Molecular Influenza Diagnostic Market Share by Application (2015-2020) Table 52. Japan Key Players Molecular Influenza Diagnostic Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Molecular Influenza Diagnostic Market Share (2019-2020) Table 54. Japan Molecular Influenza Diagnostic Market Size by Type (2015-2020) (Million US$) Table 55. Japan Molecular Influenza Diagnostic Market Share by Type (2015-2020) Table 56. Japan Molecular Influenza Diagnostic Market Size by Application (2015-2020) (Million US$) Table 57. Japan Molecular Influenza Diagnostic Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players Molecular Influenza Diagnostic Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players Molecular Influenza Diagnostic Market Share (2019-2020) Table 60. Southeast Asia Molecular Influenza Diagnostic Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia Molecular Influenza Diagnostic Market Share by Type (2015-2020) Table 62. Southeast Asia Molecular Influenza Diagnostic Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia Molecular Influenza Diagnostic Market Share by Application (2015-2020) Table 64. India Key Players Molecular Influenza Diagnostic Revenue (2019-2020) (Million US$) Table 65. India Key Players Molecular Influenza Diagnostic Market Share (2019-2020) Table 66. India Molecular Influenza Diagnostic Market Size by Type (2015-2020) (Million US$) Table 67. India Molecular Influenza Diagnostic Market Share by Type (2015-2020) Table 68. India Molecular Influenza Diagnostic Market Size by Application (2015-2020) (Million US$) Table 69. India Molecular Influenza Diagnostic Market Share by Application (2015-2020) Table 70. Central & South America Key Players Molecular Influenza Diagnostic Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players Molecular Influenza Diagnostic Market Share (2019-2020) Table 72. Central & South America Molecular Influenza Diagnostic Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America Molecular Influenza Diagnostic Market Share by Type (2015-2020) Table 74. Central & South America Molecular Influenza Diagnostic Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America Molecular Influenza Diagnostic Market Share by Application (2015-2020) Table 76. BD Company Details Table 77. BD Business Overview Table 78. BD Product Table 79. BD Revenue in Molecular Influenza Diagnostic Business (2015-2020) (Million US$) Table 80. BD Recent Development Table 81. Abbott (Include Alere) Company Details Table 82. Abbott (Include Alere) Business Overview Table 83. Abbott (Include Alere) Product Table 84. Abbott (Include Alere) Revenue in Molecular Influenza Diagnostic Business (2015-2020) (Million US$) Table 85. Abbott (Include Alere) Recent Development Table 86. Roche Company Details Table 87. Roche Business Overview Table 88. Roche Product Table 89. Roche Revenue in Molecular Influenza Diagnostic Business (2015-2020) (Million US$) Table 90. Roche Recent Development Table 91. SIEMENS Company Details Table 92. SIEMENS Business Overview Table 93. SIEMENS Product Table 94. SIEMENS Revenue in Molecular Influenza Diagnostic Business (2015-2020) (Million US$) Table 95. SIEMENS Recent Development Table 96. Analytik Jena Company Details Table 97. Analytik Jena Business Overview Table 98. Analytik Jena Product Table 99. Analytik Jena Revenue in Molecular Influenza Diagnostic Business (2015-2020) (Million US$) Table 100. Analytik Jena Recent Development Table 101. Quidel Company Details Table 102. Quidel Business Overview Table 103. Quidel Product Table 104. Quidel Revenue in Molecular Influenza Diagnostic Business (2015-2020) (Million US$) Table 105. Quidel Recent Development Table 106. Thermo Fisher Company Details Table 107. Thermo Fisher Business Overview Table 108. Thermo Fisher Product Table 109. Thermo Fisher Revenue in Molecular Influenza Diagnostic Business (2015-2020) (Million US$) Table 110. Thermo Fisher Recent Development Table 111. Meridian Bioscience Business Overview Table 112. Meridian Bioscience Product Table 113. Meridian Bioscience Company Details Table 114. Meridian Bioscience Revenue in Molecular Influenza Diagnostic Business (2015-2020) (Million US$) Table 115. Meridian Bioscience Recent Development Table 116. BioMerieux Company Details Table 117. BioMerieux Business Overview Table 118. BioMerieux Product Table 119. BioMerieux Revenue in Molecular Influenza Diagnostic Business (2015-2020) (Million US$) Table 120. BioMerieux Recent Development Table 121. Sekisui Diagnostics Company Details Table 122. Sekisui Diagnostics Business Overview Table 123. Sekisui Diagnostics Product Table 124. Sekisui Diagnostics Revenue in Molecular Influenza Diagnostic Business (2015-2020) (Million US$) Table 125. Sekisui Diagnostics Recent Development Table 126. Response Biomedical Company Details Table 127. Response Biomedical Business Overview Table 128. Response Biomedical Product Table 129. Response Biomedical Revenue in Molecular Influenza Diagnostic Business (2015-2020) (Million US$) Table 130. Response Biomedical Recent Development Table 131. SA Scientific Company Details Table 132. SA Scientific Business Overview Table 133. SA Scientific Product Table 134. SA Scientific Revenue in Molecular Influenza Diagnostic Business (2015-2020) (Million US$) Table 135. SA Scientific Recent Development Table 136. Research Programs/Design for This Report Table 137. Key Data Information from Secondary Sources Table 138. Key Data Information from Primary Sources List of Figures Figure 1. Global Molecular Influenza Diagnostic Market Share by Type: 2020 VS 2026 Figure 2. Reverse Transcription Polymerase Chain Reaction (RT-PCR) Features Figure 3. Nucleic Acid Sequence Based Amplification (NASBA) Tests Features Figure 4. Loop-mediated Isothermal Amplification-Based Assays (LAMP) Features Figure 5. Simple Amplification-based Assays (SAMBA) Features Figure 6. Global Molecular Influenza Diagnostic Market Share by Application: 2020 VS 2026 Figure 7. Hospitals Case Studies Figure 8. POCT Case Studies Figure 9. Others Case Studies Figure 10. Molecular Influenza Diagnostic Report Years Considered Figure 11. Global Molecular Influenza Diagnostic Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Molecular Influenza Diagnostic Market Share by Regions: 2020 VS 2026 Figure 13. Global Molecular Influenza Diagnostic Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Molecular Influenza Diagnostic Market Share by Players in 2019 Figure 16. Global Top Molecular Influenza Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Influenza Diagnostic as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Molecular Influenza Diagnostic Revenue in 2019 Figure 18. North America Molecular Influenza Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Molecular Influenza Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Molecular Influenza Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Molecular Influenza Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Molecular Influenza Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Molecular Influenza Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Molecular Influenza Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 25. BD Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. BD Revenue Growth Rate in Molecular Influenza Diagnostic Business (2015-2020) Figure 27. Abbott (Include Alere) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Abbott (Include Alere) Revenue Growth Rate in Molecular Influenza Diagnostic Business (2015-2020) Figure 29. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Roche Revenue Growth Rate in Molecular Influenza Diagnostic Business (2015-2020) Figure 31. SIEMENS Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. SIEMENS Revenue Growth Rate in Molecular Influenza Diagnostic Business (2015-2020) Figure 33. Analytik Jena Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Analytik Jena Revenue Growth Rate in Molecular Influenza Diagnostic Business (2015-2020) Figure 35. Quidel Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Quidel Revenue Growth Rate in Molecular Influenza Diagnostic Business (2015-2020) Figure 37. Thermo Fisher Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Thermo Fisher Revenue Growth Rate in Molecular Influenza Diagnostic Business (2015-2020) Figure 39. Meridian Bioscience Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Meridian Bioscience Revenue Growth Rate in Molecular Influenza Diagnostic Business (2015-2020) Figure 41. BioMerieux Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. BioMerieux Revenue Growth Rate in Molecular Influenza Diagnostic Business (2015-2020) Figure 43. Sekisui Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Sekisui Diagnostics Revenue Growth Rate in Molecular Influenza Diagnostic Business (2015-2020) Figure 45. Response Biomedical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Response Biomedical Revenue Growth Rate in Molecular Influenza Diagnostic Business (2015-2020) Figure 47. SA Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. SA Scientific Revenue Growth Rate in Molecular Influenza Diagnostic Business (2015-2020) Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation

BD Abbott (Include Alere) Roche SIEMENS Analytik Jena Quidel Thermo Fisher Meridian Bioscience BioMerieux Sekisui Diagnostics Response Biomedical SA Scientific